UNCG Campus Weekly

Campus Weekly is published each Wednesday when classes are in session. In the summer, it is published biweekly.

Dr. Christopher Kepley

Photo of Dr. Christopher KepleyDr. Christopher Kepley (Joint School of Nanoscience and Nanoengineering) received additional funding from the Tunitas Therapeutics for the project “A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma.” The overall goal of this proposal is to position a novel biologic for human clinical trials in allergic disease though the completion of critical preclinical development research activities. GE2, a genetically engineered human fusion protein consisting of portions of the human gamma1 Fc linked to portions of the human epsilon Fc chain, has unique mechanistic properties that should translate to a next-generation therapeutic option for patients with severe allergic asthma and food allergy.